Rachel Klemovitch, Assistant Editor04.08.24
Privately held medical device company, Accelus has appointed Rob German as vice president of research and development and Luke Perkins as senior director of product management. These appointments underscore the company’s commitment to drive innovation.
Accelus president and CEO, Kevin McGann commented, "The addition of Rob and Luke to our team marks a significant milestone in our journey. Their extensive experience and visionary leadership will undoubtedly accelerate our mission to lead in expandable spinal implant technology. We are poised for an exciting phase of innovation and growth, and I’m excited to have Rob and Luke leading our product development and marketing teams moving forward."
German joins Accelus with over two decades of experience in the medical device industry. In 2005, he joined NuVasive as VP of product development after working at three orthopedic start-ups for ten years.
“Accelus has the qualities that everyone in product development looks for: a talented group of people who are culture-forward, focused on speed, and possess a truly differentiating platform,” German said. “I am excited to join the Accelus team in their mission to become a global leader in expandable spinal implant technology.”
Perkins has 25 years of experience in medical device and healthcare marketing. He previously launched market-making minimally invasive spinal procedures, led premarket approvals for several Class III devices, and integrated advanced computer-assisted surgery technologies into operating rooms.
Prior to Accelus, Perkins spent over eight years at NuVassive working in product and marketing development, as well as at Medtronic Spine & Biologics in marketing and development. Most recently, he served at StartBox Inc., where he focused on eliminating wrong-site surgery, providing him with insight into patient safety.
"I am excited to embark on this new journey with Accelus, where I feel we have the opportunity to not only advance clinical outcomes but also to enhance the surgical experience," Perkins said. "My goal is to lead our product management team in harnessing the incredible potential of our expandable implant technologies, ensuring surgeons know the potential Accelus products hold for their patients and surgeries."
Accelus president and CEO, Kevin McGann commented, "The addition of Rob and Luke to our team marks a significant milestone in our journey. Their extensive experience and visionary leadership will undoubtedly accelerate our mission to lead in expandable spinal implant technology. We are poised for an exciting phase of innovation and growth, and I’m excited to have Rob and Luke leading our product development and marketing teams moving forward."
German joins Accelus with over two decades of experience in the medical device industry. In 2005, he joined NuVasive as VP of product development after working at three orthopedic start-ups for ten years.
“Accelus has the qualities that everyone in product development looks for: a talented group of people who are culture-forward, focused on speed, and possess a truly differentiating platform,” German said. “I am excited to join the Accelus team in their mission to become a global leader in expandable spinal implant technology.”
Perkins has 25 years of experience in medical device and healthcare marketing. He previously launched market-making minimally invasive spinal procedures, led premarket approvals for several Class III devices, and integrated advanced computer-assisted surgery technologies into operating rooms.
Prior to Accelus, Perkins spent over eight years at NuVassive working in product and marketing development, as well as at Medtronic Spine & Biologics in marketing and development. Most recently, he served at StartBox Inc., where he focused on eliminating wrong-site surgery, providing him with insight into patient safety.
"I am excited to embark on this new journey with Accelus, where I feel we have the opportunity to not only advance clinical outcomes but also to enhance the surgical experience," Perkins said. "My goal is to lead our product management team in harnessing the incredible potential of our expandable implant technologies, ensuring surgeons know the potential Accelus products hold for their patients and surgeries."